Dr Chris Jackson: Cancer researcher says mRNA technology has potential

episode

Best of Business not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

More from Best of Business

Jannet Xuccoa: When's the right time for a trust? 44 min · 21 Dec 2025

All episodes from Best of Business →

Report any issue

Source

Recorded17 Oct 2022

Publisheromnycontent.com ↗

Handlerec:7248980

Show notes

Hopes our new knowledge of vaccines will help to cure cancer - within the next decade. The founders of BioNTech, who collaborated with Pfizer to create New Zealand's most effective Covid vaccine, are working on an injection to target different types of cancer. It should be available before 2030. The jab uses the same mRNA technology as found in the Covid jab, to assist the immune system to fight off cancer cells. New Zealand cancer researcher Dr Chris Jackson told Mike Hosking the development has potential. LISTEN ABOVESee omnystudio.com/listener for privacy information.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.